Terms: = Pancreatic cancer AND TP53, TRP53, 7157, ENSG00000141510, P04637, LFS1, P53 AND Staging
21 results:
1. Long non-coding RNA LINC-PINT as a novel prognostic biomarker in human cancer: a meta-analysis and machine learning.
Lin J; Chen L; Zhang D
Sci Rep; 2024 Mar; 14(1):7483. PubMed ID: 38553526
[TBL] [Abstract] [Full Text] [Related]
2. Negative p53 Expression Confers Worse Prognosis in Patients With Resected pancreatic Ductal Adenocarcinoma: Research Focused on Reinterpretation of Immunohistochemical Staining.
Li B; Wang Y; Wang J; Zhang G; Yin X; Wang H; Jiang H; Jin G; Guo S
Pancreas; 2022 Oct; 51(9):1217-1224. PubMed ID: 37078948
[TBL] [Abstract] [Full Text] [Related]
3. Does the Overall Survival of the Resectable Periampullary Carcinomas Correlate with High Expression of p53 and ki67?
Rusu-Andriesi D; Trofin AM; Zabara M; Vlad N; Vasiluta C; Vasilescu A; Blaj M; Spiridon I; Cadar R; Lovin O; Crumpei F; Tarcoveanu E; Lupascu-Ursulescu C; Lupascu C
Chirurgia (Bucur); 2022 Jun; 117(4):423-430. PubMed ID: 36049099
[No Abstract] [Full Text] [Related]
4. Molecular profile of pancreatic neuroendocrine neoplasms (PanNENs): Opportunities for personalized therapies.
Arakelyan J; Zohrabyan D; Philip PA
Cancer; 2021 Feb; 127(3):345-353. PubMed ID: 33270905
[TBL] [Abstract] [Full Text] [Related]
5. Lymphatic vessel remodeling and invasion in pancreatic cancer progression.
Shen CN; Goh KS; Huang CR; Chiang TC; Lee CY; Jeng YM; Peng SJ; Chien HJ; Chung MH; Chou YH; Hsieh CC; Kulkarni S; Pasricha PJ; Tien YW; Tang SC
EBioMedicine; 2019 Sep; 47():98-113. PubMed ID: 31495721
[TBL] [Abstract] [Full Text] [Related]
6. Genetic Changes of P
Shukla SK; Singh G; Shahi KS; Bhuvan ; Pant P
J Gastrointest Cancer; 2020 Jun; 51(2):552-559. PubMed ID: 31396884
[TBL] [Abstract] [Full Text] [Related]
7. Glucose metabolism during tumorigenesis in the genetic mouse model of pancreatic cancer.
Pasquale V; Dugnani E; Liberati D; Marra P; Citro A; Canu T; Policardi M; Valla L; Esposito A; Piemonti L
Acta Diabetol; 2019 Sep; 56(9):1013-1022. PubMed ID: 30989379
[TBL] [Abstract] [Full Text] [Related]
8. Overexpression of PARPBP Correlates with Tumor Progression and Poor Prognosis in Hepatocellular Carcinoma.
Yu B; Ding Y; Liao X; Wang C; Wang B; Chen X
Dig Dis Sci; 2019 Oct; 64(10):2878-2892. PubMed ID: 30949905
[TBL] [Abstract] [Full Text] [Related]
9. Tumor-Infiltrating Platelets Predict Postsurgical Survival in Patients with pancreatic Ductal Adenocarcinoma.
Zhang SR; Yao L; Wang WQ; Xu JZ; Xu HX; Jin W; Gao HL; Wu CT; Qi ZH; Li H; Li S; Ni QX; Yu XJ; Fu DL; Liu L
Ann Surg Oncol; 2018 Dec; 25(13):3984-3993. PubMed ID: 30171511
[TBL] [Abstract] [Full Text] [Related]
10. Endoscopic ultrasound-guided fine-needle aspiration cytology in pancreaticobiliary carcinomas: diagnostic efficacy of cell-block immunocytochemistry.
Ieni A; Todaro P; Crino SF; Barresi V; Tuccari G
Hepatobiliary Pancreat Dis Int; 2015 Jun; 14(3):305-12. PubMed ID: 26063033
[TBL] [Abstract] [Full Text] [Related]
11. Clinicopathologic study of 62 acinar cell carcinomas of the pancreas: insights into the morphology and immunophenotype and search for prognostic markers.
La Rosa S; Adsay V; Albarello L; Asioli S; Casnedi S; Franzi F; Marando A; Notohara K; Sessa F; Vanoli A; Zhang L; Capella C
Am J Surg Pathol; 2012 Dec; 36(12):1782-95. PubMed ID: 23026929
[TBL] [Abstract] [Full Text] [Related]
12. Loss of heterozygosity predicts poor survival after resection of pancreatic adenocarcinoma.
Franko J; Krasinskas AM; Nikiforova MN; Zarnescu NO; Lee KK; Hughes SJ; Bartlett DL; Zeh HJ; Moser AJ
J Gastrointest Surg; 2008 Oct; 12(10):1664-72; discussion 1672-3. PubMed ID: 18677542
[TBL] [Abstract] [Full Text] [Related]
13. [pancreatic cancer].
Schmid RM
Praxis (Bern 1994); 2006 Nov; 95(44):1709-12. PubMed ID: 17111879
[TBL] [Abstract] [Full Text] [Related]
14. ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer.
Locker GY; Hamilton S; Harris J; Jessup JM; Kemeny N; Macdonald JS; Somerfield MR; Hayes DF; Bast RC;
J Clin Oncol; 2006 Nov; 24(33):5313-27. PubMed ID: 17060676
[TBL] [Abstract] [Full Text] [Related]
15. Clinicopathological significance of p53 and mdm2 protein expression in human pancreatic cancer.
Dong M; Ma G; Tu W; Guo KJ; Tian YL; Dong YT
World J Gastroenterol; 2005 Apr; 11(14):2162-5. PubMed ID: 15810085
[TBL] [Abstract] [Full Text] [Related]
16. Immunohistochemistry can help distinguish metastatic pancreatic adenocarcinomas from bile duct adenomas and hamartomas of the liver.
Hornick JL; Lauwers GY; Odze RD
Am J Surg Pathol; 2005 Mar; 29(3):381-9. PubMed ID: 15725808
[TBL] [Abstract] [Full Text] [Related]
17. Copy number of cancer genes predict tumor grade and survival of pancreatic cancer patients.
Nagy A; Kozma L; Kiss I; Ember I; Takacs I; Hajdu J; Farid NR
Anticancer Res; 2001; 21(2B):1321-5. PubMed ID: 11396207
[TBL] [Abstract] [Full Text] [Related]
18. Colloid (mucinous noncystic) carcinoma of the pancreas.
Adsay NV; Pierson C; Sarkar F; Abrams J; Weaver D; Conlon KC; Brennan MF; Klimstra DS
Am J Surg Pathol; 2001 Jan; 25(1):26-42. PubMed ID: 11145249
[TBL] [Abstract] [Full Text] [Related]
19. Prognostic factors in resectable pancreatic cancer: p53 and bcl-2.
Bold RJ; Hess KR; Pearson AS; Grau AM; Sinicrope FA; Jennings M; McConkey DJ; Bucana CD; Cleary KR; Hallin PA; Chiao PJ; Abbruzzese JL; Evans DB
J Gastrointest Surg; 1999; 3(3):263-77. PubMed ID: 10481119
[TBL] [Abstract] [Full Text] [Related]
20. Advances in the early detection, diagnosis, and staging of pancreatic cancer.
Riker A; Libutti SK; Bartlett DL
Surg Oncol; 1997 Nov; 6(3):157-69. PubMed ID: 9576631
[TBL] [Abstract] [Full Text] [Related]
[Next]
